Funds · 13F filer · Naarden, P7

Fcpm III Services B.v.

$750.4M in 11 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+106.7%S&P 500 +20.9%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since December 31, 2023: $215 against $157 in the S&P 500.2

Fcpm III Services B.v.S&P 500 (SPY)
$100$21520232026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
Newamsterdam Pharma CompanyCUSIP N62509109$287.7M38.3%−7.7%
MPLTMaplight Therapeutics Inc$115.6M15.4%
DYNDyne Therapeutics Inc$85.5M11.4%−17.1%
VORVor Biopharma Inc$75.8M10.1%
Damora Therapeutics IncCUSIP 36322Q206$63.5M8.5%
REPLReplimune Group Inc$31.1M4.1%
Crescent Biopharma Inc.CUSIP G2545C104$30.2M4.0%
AURAAura Biosciences Inc$28.8M3.8%New
Engene Holdings IncCUSIP 29286M105$16.7M2.2%
BCYCBicycle Therapeutics PLC$14.7M2.0%
Engene Holdings IncCUSIP 29286M113$834K0.1%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
Newamsterdam Pharma CompanyCUSIP N62509109December 31, 2023+203.4%$287.7M
MPLTMaplight Therapeutics IncDecember 31, 2025+104.0%$115.6M
DYNDyne Therapeutics IncDecember 31, 2023+67.0%$85.5M
Crescent Biopharma Inc.CUSIP G2545C104December 31, 2025+51.8%$30.2M
REPLReplimune Group IncDecember 31, 2023+31.3%$31.1M
Damora Therapeutics IncCUSIP 36322Q206March 31, 2026+0.4%$63.5M
BCYCBicycle Therapeutics PLCJune 30, 2024−79.1%$14.7M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+14.9%+14.8%
March 31, 2026−5.1%−4.6%
December 31, 2025+34.9%+2.4%
September 30, 2025+40.6%+7.8%
June 30, 2025−11.0%+10.5%
March 31, 2025−31.5%−4.6%
December 31, 2024+3.2%+2.1%
September 30, 2024−5.1%+5.4%
June 30, 2024−8.8%+4.0%
March 31, 2024+91.0%+10.0%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 2013410
  2. 2
    Filed August 14, 2026 · accession 0001193125-26-350207